Hinge Health Jumps 17% on 50.7% Revenue Growth and 25% 2026 Guidance
Hinge Health grew 2025 revenue 50.7% to $587.9 million, with Q4 revenue up 45% to $170.7 million and net profit rising 440% to $31.09 million despite a net loss of $424 million. The company guided 2026 revenue to $732–742 million (25% growth) and Q1 to $171–173 million (39% growth).
1. Stock Rally
Hinge Health extended its winning streak to three days, surging 17.28% to close at $38.76 as investors reacted to stronger-than-expected revenue performance.
2. 2025 Financial Performance
The company reported full-year 2025 revenue of $587.86 million, up 50.7% year-on-year. In Q4, revenue rose 45% to $170.7 million and net income climbed 440% to $31.09 million, although the net loss widened to $424 million.
3. 2026 Outlook
Hinge Health issued guidance for full-year 2026 revenue of $732 million to $742 million (25% growth at midpoint) and Q1 revenue of $171 million to $173 million (39% growth), citing strong commercial momentum, expanding margins and robust cash generation.